| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |